• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Fertility-Sparing Treatment for Early-Stage Cervical Cancer 2 cm or Larger in Size: A Problem Still Open.

作者信息

Ronsini Carlo, Solazzo Maria Cristina, Bizzarri Nicolò, Ambrosio Domenico, La Verde Marco, Torella Marco, Carotenuto Raffaela Maria, Cobellis Luigi, Colacurci Nicola, De Franciscis Pasquale

机构信息

Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy.

Unit of Gynecologic Oncology, Department of Woman, Child and Public Health, A. Gemelli, IRCCS, University Hospital Foundation, Rome, Italy.

出版信息

Ann Surg Oncol. 2022 Dec;29(13):8359-8360. doi: 10.1245/s10434-022-12556-3. Epub 2022 Sep 15.

DOI:10.1245/s10434-022-12556-3
PMID:36109409
Abstract
摘要

相似文献

1
ASO Author Reflections: Fertility-Sparing Treatment for Early-Stage Cervical Cancer 2 cm or Larger in Size: A Problem Still Open.ASO作者反思：对直径2厘米或更大的早期宫颈癌进行保留生育功能治疗：一个仍未解决的问题。
Ann Surg Oncol. 2022 Dec;29(13):8359-8360. doi: 10.1245/s10434-022-12556-3. Epub 2022 Sep 15.
2
Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy.宫颈癌 2cm 以上（国际妇产科联合会 2009 年分期 IB1-IIA）患者行新辅助化疗后行保留生育功能的手术。
Int J Gynecol Cancer. 2020 Jan;30(1):115-121. doi: 10.1136/ijgc-2019-000647. Epub 2019 Nov 19.
3
Fertility-sparing surgery after neo-adjuvant chemotherapy in women with cervical cancer larger than 4 cm: a systematic review.新辅助化疗后对直径大于4厘米的宫颈癌女性进行保留生育功能手术：一项系统评价
Int J Gynecol Cancer. 2022 Apr 4;32(4):486-493. doi: 10.1136/ijgc-2021-003297.
4
Neo-adjuvant chemotherapy in fertility-sparing cervical cancer treatment.新辅助化疗在保留生育功能宫颈癌治疗中的应用。
Best Pract Res Clin Obstet Gynaecol. 2021 Sep;75:82-100. doi: 10.1016/j.bpobgyn.2021.01.010. Epub 2021 Feb 20.
5
Oncological and obstetrical outcomes after neo-adjuvant chemotherapy followed by fertility-sparing surgery in patients with cervical cancer ≥2 cm.新辅助化疗后行保留生育功能手术治疗≥2cm 宫颈癌患者的肿瘤学和产科结局。
Int J Gynecol Cancer. 2021 Mar;31(3):462-467. doi: 10.1136/ijgc-2020-002076. Epub 2020 Nov 16.
6
Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.新辅助化疗后行大锥形切除术作为IB期宫颈癌保留生育功能的治疗方法。
Gynecol Oncol. 2015 Dec;139(3):447-51. doi: 10.1016/j.ygyno.2015.05.043. Epub 2015 Jun 4.
7
FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study.FIGO 2018 期 IB2（2-4 厘米）宫颈癌采用新辅助化疗后行保留生育功能的手术治疗（CONTESSA）；宫颈癌新辅助化疗联合保留生育功能的保守性手术（NEOCON-F）。一项 PMHC、DGOG、GCIG/CCRN 和多中心研究。
Int J Gynecol Cancer. 2019 Jun;29(5):969-975. doi: 10.1136/ijgc-2019-000398. Epub 2019 May 17.
8
Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2-4 cm; emerging data and future perspectives.新辅助化疗后行保留生育功能手术治疗 2-4cm 宫颈癌：新兴数据与未来展望。
Gynecol Oncol. 2021 Sep;162(3):809-815. doi: 10.1016/j.ygyno.2021.06.006. Epub 2021 Jun 12.
9
Fertility sparing treatment for cervical cancer.宫颈癌的保留生育功能治疗。
Best Pract Res Clin Obstet Gynaecol. 2021 Sep;75:1. doi: 10.1016/j.bpobgyn.2021.08.001.
10
Long-term outcomes after fertility-sparing laparoscopic radical trachelectomy in young women with early-stage cervical cancer: an Asan Gynecologic Cancer Group (AGCG) study.年轻早期宫颈癌患者行保留生育功能腹腔镜根治性子宫颈切除术的长期结局：一个 Asan 妇科癌症组（AGCG）的研究。
J Surg Oncol. 2014 Sep;110(3):252-7. doi: 10.1002/jso.23631. Epub 2014 May 26.

引用本文的文献

1
Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA.基于 RNA 干扰的肝细胞癌治疗的最新进展：重点是 siRNA。
Cell Biochem Biophys. 2024 Sep;82(3):1947-1964. doi: 10.1007/s12013-024-01395-6. Epub 2024 Jul 10.
2
Whole-tumor histogram analysis of apparent diffusion coefficients for predicting lymphovascular space invasion in stage IB-IIA cervical cancer.通过全肿瘤表观扩散系数直方图分析预测IB-IIA期宫颈癌的脉管间隙浸润
Front Oncol. 2023 Jun 19;13:1206659. doi: 10.3389/fonc.2023.1206659. eCollection 2023.

本文引用的文献

1
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.《欧洲妇科肿瘤学会/欧洲放射肿瘤学会/欧洲病理学会宫颈癌管理指南》。
Int J Gynecol Cancer. 2018 May;28(4):641-655. doi: 10.1097/IGC.0000000000001216.
2
Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review.保留生育功能的宫颈癌手术的肿瘤学结局：系统综述。
Lancet Oncol. 2016 Jun;17(6):e240-e253. doi: 10.1016/S1470-2045(16)30032-8.